One too Many? The link between alcohol and cancer
Join C3 Collaborating for Health and The George Institute this London Global Cancer Week (11-17 November 2023) as we explore how best to reduce alcohol consumption and raise awareness in the global fight against cancer.
- Time: 16th November 2023
- Date: 08:30-10:00 GMT/ 09:30-11:00 CET/14:00-15:30 IST/19:30-21:00 AEST
- Format: Online
Cancer has become the second leading cause of death globally. Cancer impacts on national economies through increased out-of-pocket health expenditure, labour, and productivity losses, which often drives families caring for cancer patients into poverty. London Global Cancer Week (LGCW) brings together researchers, policy makers, health professionals and other key stakeholders from across the world to create a 360° picture of the impact of the rising global prevalence of cancer, and the challenges the cancer pandemic poses to realising Universal health coverage.
Even small amounts of alcohol can increase your risk of cancer, so the more you can cut down the more you can reduce the risk. In this session, experts from different sectors will discuss how alcohol contributes to cancer risk and how we can best address alcohol consumption and raise awareness of its health risks by sharing evidence-based approaches for reducing alcohol consumption in societies where ‘drinking’ is a socio-cultural norm. During the Q&A, audience members will have the opportunity to provide new insights and opportunities for change.
Agenda (times are displayed in GMT)
- 08:30-08:50 - Opening remarks and introductions from speakers (Christine Hancock, Founder & Director, C3 Collaborating for Health)
- 08:50-09:00 - Proven policy solutions to raise awareness and prevent cancer cases and deaths due to alcohol across the globe (Maik Dünnbier, Director of Advocacy and Strategy, Movendi International)
- 09:00-09:30 - Panel discussion: regional exchange on progress and priorities
- Dr Carina Ferreira-Borges, Regional Advisor Alcohol, illicit drugs, prison health, WHO Regional Office for Europe
- Liz Arnanz, Policy and Advocacy Manager, NCD Alliance
- Professor Simone Pettigrew, Director of Health Promotion and Behaviour Change, The George Institute for Global Health
- 09:30-09:55 – Q & A
- 09:55-10:00 - Closing remarks (Christine Hancock, Founder & Director, C3 Collaborating for Health)
Dr Carina Ferreira-Borges
Dr Carina Ferreira-Borges is a public health specialist with an interest in non-communicable diseases and holds a PhD in International Health. She joined WHO in 2006 dedicating her work to strengthening WHO normative and technical support to countries namely the development of comprehensive national policies aimed at reducing alcohol consumption and the improvement of prison health systems. In addition, Carina was Head of the WHO Office for Prevention and Control of NCDs and NCD Director providing strategic and technical support to 53 Member States of the Region in scaling up their efforts to better prevent and control noncommunicable diseases.
Christine Hancock is the founder and director of C3 Collaborating for Health, a UK-based NGO aimed at preventing NCDs. She is a graduate of the London School of Economics and an experienced nurse and health service manager.
Liz Arnanz is responsible for NCD Alliance’s policy and advocacy work on noncommunicable disease (NCD) prevention and health promotion, by advocating and supporting the implementation of regulations and policies that reduce exposure to the main NCD risk factors and address the social and commercial determinants of health. Prior to this, she worked at FDI World Dental Federation, advocating for the integration of oral health promotion and care within health systems and public health policy, and for the partnerships and membership team of the NCD Alliance. She also has experience in the field of humanitarian aid and protection and has been a consultant with the UN Population Fund (UNFPA). She holds a Master’s degree in European Interdisciplinary Studies from the College of Europe, and is fluent in English, French and Spanish.
Maik Dünnbier from Cottbus, Germany, is the first ever Director of Strategy and Advocacy in the 170-year long history of Movendi International. He works closely together with the Executive Director and advises the President and International Board on strategic questions and advocacy issues. Maik is a political scientist, advocacy specialist, civil society activist, communication expert, fearless thinker and innovator, a Human Rights defender and humanist. Maik leads Movendi International with creativity, heart-driven passion, and critical thinking. Maik’s work is guided and inspired by their vision for a world where free and healthy citizens actively contribute to all levels of society.
Professor Simone Pettigrew
Professor Simone Pettigrew is Director of Health Promotion and Behaviour Change. She has qualifications in Economics, Marketing, and Consumer Psychology. Her broad areas of expertise include behavioural psychology, health promotion, health policy, communications, social marketing, and intervention research. Her substantive areas of research include alcohol consumption, smoking, vaping, nutrition, obesity, physical activity, active transport, and healthy ageing. Simone sits on numerous advisory committees and regularly performs research consultancies for NGO and government entities. To date, she has published more than 400 peer-reviewed papers and produced more than 160 technical reports for NGOs and government departments.